Risk Factor for Diabetes Mellitus and High Blood Glucose With HMG‐CoA Reductase Inhibitors Using a Postmarketing Surveillance Database in Japan
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.444
Abstract: To investigate whether 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase inhibitor (statin) use is associated with an increased risk of diabetes mellitus and hyperglycemia, we performed a nested case‐control study using a postmarketing surveillance database in Japan. The database… read more here.
Keywords: statin use; diabetes mellitus; mellitus hyperglycemia; risk ... See more keywords